◂ RESEARCH LIBRARY
CJC-1295 + Ipamorelin research peptide

Research Overview

CJC-1295 + Ipamorelin

CJC-1295 no-DAC (Mod GRF 1-29) 5mg · Ipamorelin 5mg blend

CoA on requestPurity CoAResearch use only

In 60 seconds

This is a blend rather than a single compound, and no published study has evaluated this specific two-peptide combination — the evidence below is the literature for each constituent, cited separately.

  • Measured GH responses to GHRH(1-29)-NH2 and a D-Ala2-substituted analogue in normal men across a dose range.
  • Systematic substitution scans of hGHRH(1-29)-NH2 identified positions that yield potent agonists.
  • Characterised ipamorelin as a GH secretagogue with selectivity comparable to GHRH.

OVERVIEW

CJC-1295 + Ipamorelin (CJC-1295 no-DAC (Mod GRF 1-29) 5mg · Ipamorelin 5mg blend) is a research-grade peptide supplied by Living Water Labs for laboratory investigation. Single-vial blend: 5 mg CJC-1295 (no DAC) + 5 mg Ipamorelin — 10 mg total, lyophilised.. Each published certificate is an independent Janoshik Analytical report naming the compound and its HPLC purity; certificates not yet published can be requested. The summary below outlines documented mechanisms and study areas reported in the research literature.

Scientific name

CJC-1295 no-DAC (Mod GRF 1-29) 5mg · Ipamorelin 5mg blend

Molecular weight

Blend (3367.9 / 711.9 g/mol)

Vial size

10mg

DOCUMENTED RESEARCH AREAS

  • ▸Single-vial blend — two GH-axis peptides lyophilised together
  • ▸10 mg total: 5 mg CJC-1295 (no DAC) + 5 mg Ipamorelin
  • ▸GHRH-receptor and ghrelin-receptor (GHS-R1a) research in one vial
  • ▸Short-acting no-DAC GHRH analogue, not the long-acting DAC version
  • ▸Supplied for laboratory research use only

MECHANISM OF ACTION

This is a blend rather than a single compound, and no published study has evaluated this specific two-peptide combination — the evidence below is the literature for each constituent, cited separately. The rationale for pairing them is that they act on the two receptors that shape a growth-hormone pulse: CJC-1295 without DAC (modified GRF 1-29) at the pituitary GHRH receptor, and Ipamorelin at the ghrelin receptor (GHS-R1a).

  • ▸CJC-1295 no-DAC — stabilised GHRH(1-29) analogue acting at the pituitary GHRH receptor
  • ▸Ipamorelin — selective ghrelin-receptor (GHS-R1a) agonist
  • ▸No study has tested the two together as a blend; combination effects are unestablished

STUDY SUMMARIES

3 peer-reviewed references

Peptides · 1985

Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men

Measured GH responses to GHRH(1-29)-NH2 and a D-Ala2-substituted analogue in normal men across a dose range.

View on PubMed (PMID 2866496)

J Med Chem · 1998

Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies

Systematic substitution scans of hGHRH(1-29)-NH2 identified positions that yield potent agonists.

View on PubMed (PMID 9513600)

Eur J Endocrinol · 1998

Ipamorelin, the first selective growth hormone secretagogue

Characterised ipamorelin as a GH secretagogue with selectivity comparable to GHRH.

View on PubMed (PMID 9849822)

CITATIONS

  1. 1.Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men. Peptides. 1985. PMID 2866496. pubmed.ncbi.nlm.nih.gov/2866496
  2. 2.Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies. J Med Chem. 1998. PMID 9513600. pubmed.ncbi.nlm.nih.gov/9513600
  3. 3.Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998. PMID 9849822. pubmed.ncbi.nlm.nih.gov/9849822

Citations describe findings reported in the referenced preclinical, in-vitro or clinical literature. They are provided for research and educational purposes only and are not a therapeutic claim.

EXPLORE VARIANTS Back to Library
Look up a purity CoAHow-to guidesReconstitution toolGlossary

Research Tool

Peptide Reconstitution Calculator

Concentration, draw volume & syringe units in seconds.

All information is provided for research and educational purposes only and describes findings in preclinical/in-vitro literature. Not medical advice. Products are supplied strictly for research purposes — not for human consumption.

Related Research & Reading

Keep exploring — goal collections, plain-language guides and the wellness journal, all in one place.

Research Axes · 22 Goals

Shop by Goal

Start from what you want to change rather than from a compound name. Every goal below opens a full vertical — what the research points to, what we stock for it, and how to run it.

Browse all goals →

Health & Longevity

Systemic wellness — the compounds most studied for how you age, recover overnight and feel day to day.

Performance & Repair

Training, recovery and tissue-repair research — for getting back to the gym, the field or the trail sooner.

By Concern

Start from what you want to change — skin, hair, focus, mood, libido — and see what research points to.

Who It’s For

Curated entry points for specific researchers — women, veterinary work, first-timers and bulk buyers.

HPLC tested · Janoshik · Janoshik Certificates · Nationwide Delivery